International Society of Atopic Dermatitis Poster Presentation: Itch Reduction and Quality of Life Improvement in AD for First Human Use of Zabalafin

Clinical Presentations

International Society of Atopic Dermatitis Poster Presentation: Itch Reduction and Quality of Life Improvement in AD for First Human Use of Zabalafin NEWS PROVIDED BY Alphyn Biologics October 26, 2024, 19:30 ET N432_Neal-KOLLER_Itch-Reduction-and-Quality-of-Life-Improvement-in-AD-for-First-Human-Use-of-Zabalfin CONTACTS   Corporate: Neal Koller [email protected] (410) 690-8687   Media: Susan Thomas [email protected] (619) 540-9195

2024 European Association of Dermatology and Venerology (EADV) Poster Presentation: Itch Reduction and Quality of Life Improvement in AD for First Human Use of Zabalafin Hydrogel

Clinical Presentations

2024 European Association of Dermatology and Venerology (EADV) Poster Presentation: Itch Reduction and Quality of Life Improvement in AD for First Human Use of Zabalafin Hydrogel NEWS PROVIDED BY Alphyn Biologics September 28, 2024, 19:30 ET CONTACTS   Corporate: Neal Koller [email protected] (410) 690-8687   Media: Susan Thomas [email protected] (619) 540-9195

Society for Pediatric Dermatology Poster Presentation: First-in-Human Phase 2 Trial of Zabalafin Hydrogel (AB-101a) – Itch and Quality of Life Pediatric Results

Clinical Presentations

Society for Pediatric Dermatology Poster Presentation: First-in-Human Phase 2 Trial of Zabalafin Hydrogel (AB-101a) – Itch and Quality of Life Pediatric Results NEWS PROVIDED BY Alphyn Biologics July 8, 2024, 19:30 ET CONTACTS   Corporate: Neal Koller [email protected] (410) 690-8687   Media: Susan Thomas [email protected] (619) 540-9195

Masters of Pediatric Dermatology Symposium Poster Presentation: First in Human Phase 2 Trial of Zabalafin (AB-101) – Interim Results

Clinical Presentations

Masters of Pediatric Dermatology Symposium Poster Presentation: First in Human Phase 2 Trial of Zabalafin (AB-101) – Interim Results NEWS PROVIDED BY Alphyn Biologics February 8, 2023, 17:00 ET CONTACTS   Corporate: Neal Koller [email protected] (410) 690-8687   Media: Susan Thomas [email protected] (619) 540-9195

Society for Pediatric Dermatology Poster Presentation: Phase 2a Trial of Topical Therapeutic for Mild, Moderate, and Severe Atopic Dermatitis

Clinical Presentations

Society for Pediatric Dermatology Poster Presentation: Phase 2a Trial of Topical Therapeutic for Mild, Moderate, and Severe Atopic Dermatitis NEWS PROVIDED BY Alphyn Biologics July 13, 2023, 19:30 ET CONTACTS   Corporate: Neal Koller [email protected] (410) 690-8687   Media: Susan Thomas [email protected] (619) 540-9195

European Society for Pediatric Dermatology Poster Presentation: Pediatric Data from Phase 2a Trial of AB-101a for Mild-to-Moderate Atopic Dermatitis

Clinical Presentations

European Society for Pediatric Dermatology Poster Presentation: Pediatric Data from Phase 2a Trial of AB-101a for Mild-to-Moderate Atopic Dermatitis NEWS PROVIDED BY Alphyn Biologics May 4, 2023, 07:25 ET CONTACTS   Corporate: Neal Koller [email protected] (410) 690-8687   Media: Susan Thomas [email protected] (619) 540-9195